MEI Pharma Reports Study Of Clinical Stage Oral CDK Inhibitor Voruciclib Published In Nature Scientific Reports: 'Studies Demonstrate Repression of MCL-1 and Sensitization to BCL-2 Inhibition in Diffuse Large B-Cell Lymphoma'